Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Meritage Homes Q2 Sales $1.41B Beat $1.37B Estimate

Meritage Homes (NYSE:MTH) reported quarterly sales of $1.41 billion which beat the analyst consensus estimate of $1.37 billion by 3.07 percent. This is a 10.49 percent increase over sales of $1.28 billion the same
byBenzinga Newsdesk
July 27, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Meritage Homes (NYSE:MTH) reported quarterly sales of $1.41 billion which beat the analyst consensus estimate of $1.37 billion by 3.07 percent. This is a 10.49 percent increase over sales of $1.28 billion the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Exelixis’ Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest

By Vandana Singh
August 24, 2:46 PM
Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the phase 3 CABINET pivotal trial early due to a dramatic improvement in efficacy that was 

EXEL